Compare OGN & MD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OGN | MD |
|---|---|---|
| Founded | 1923 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.8B |
| IPO Year | 2020 | 1996 |
| Metric | OGN | MD |
|---|---|---|
| Price | $6.41 | $19.70 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 4 |
| Target Price | $11.75 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 3.9M | 894.6K |
| Earning Date | 05-14-2026 | 05-20-2026 |
| Dividend Yield | ★ 1.24% | N/A |
| EPS Growth | N/A | ★ 263.03 |
| EPS | 0.72 | ★ 1.94 |
| Revenue | ★ $6,216,000,000.00 | $1,913,849,000.00 |
| Revenue This Year | $0.42 | $3.72 |
| Revenue Next Year | $1.67 | $2.62 |
| P/E Ratio | ★ $8.98 | $10.17 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.18 | $11.84 |
| 52 Week High | $15.88 | $24.99 |
| Indicator | OGN | MD |
|---|---|---|
| Relative Strength Index (RSI) | 31.55 | 43.97 |
| Support Level | $6.34 | $16.41 |
| Resistance Level | $7.87 | $22.47 |
| Average True Range (ATR) | 0.30 | 0.93 |
| MACD | -0.09 | 0.03 |
| Stochastic Oscillator | 7.89 | 77.11 |
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.